|

NZD/USD erases early losses, edges higher toward 0.7100

  • NZD/USD is pushing higher in the second half of the day.
  • Renewed USD weakness is helping NZD/USD gain traction.
  • US stocks post strong gains on vaccine news, stimulus optimism.

After sliding to a fresh daily low of 0.7059 during the European trading hours, the NZD/USD turned north in the second half of the day and was last seen gaining 0.12% at 0.7085.

DXY loses traction as US stocks climb higher

With risk flows retaking control of financial markets during the American session, the greenback came under renewed bearish pressure and allowed NZD/USD to stage a rebound. At the moment, the US Dollar Index is down 0.18% on a daily basis at 90.55 and Wall Street's main indices are up between 0.6% and 0.9%.

Coronavirus vaccine optimism and heightened hopes for a US stimulus deal seem to have caused a positive shift in risk sentiment. Ahead of Thursday's Advisory Committee meeting, the US Food and Drug Administration (FDA) said they have not identified any specific safety concerns with Moderna's coronavirus vaccine. Meanwhile, reports from the US revealed that House Speaker Nancy Pelosi invited top congressional leaders to discuss the coronavirus relief bill later in the day. 

In the early Asian session on Wednesday, Statistics New Zealand will release the third-quarter Current Account report. Earlier in the day, the biweekly Global Dairy Trade (GDT) auction yielded a 1.3% increase in the GDT Price Index but was largely ignored by the market participants.

Technical levels to watch for

NZD/USD

Overview
Today last price0.7085
Today Daily Change0.0004
Today Daily Change %0.06
Today daily open0.7081
 
Trends
Daily SMA200.7013
Daily SMA500.6819
Daily SMA1000.6728
Daily SMA2000.6474
 
Levels
Previous Daily High0.712
Previous Daily Low0.7076
Previous Weekly High0.7114
Previous Weekly Low0.7005
Previous Monthly High0.7052
Previous Monthly Low0.6589
Daily Fibonacci 38.2%0.7093
Daily Fibonacci 61.8%0.7103
Daily Pivot Point S10.7065
Daily Pivot Point S20.7048
Daily Pivot Point S30.702
Daily Pivot Point R10.7109
Daily Pivot Point R20.7137
Daily Pivot Point R30.7153

Author

Eren Sengezer

As an economist at heart, Eren Sengezer specializes in the assessment of the short-term and long-term impacts of macroeconomic data, central bank policies and political developments on financial assets.

More from Eren Sengezer
Share:

Editor's Picks

EUR/USD struggles to hold above 1.1800 ahead of US data

EUR/USD finds it difficult to gather recovery momentum and retreats below 1.1800 in the second half of the day on Thursday. The US Dollar (USD) stays resilient against its peers after the hawkish surprise in FOMC Minutes, weighing on the pair ahead of the next batch of US data.

GBP/USD recovers above 1.3500 amid better mood

GBP/USD finds fresh demand and rises back above 1.3500 in the European session on Thursday. Improving risk sentiment and renewed US Dollar weakness are helping the pair recover ground ahead of mid-tier US data releases and Fedspeak. 

Gold retreats from daily highs, trades below $5,000

Gold finds it difficult to stabilize above the $5,000 psychological mark on Thursday and trades slightly below this level in the early American session. Escalating geopolitical tensions in the Middle East help XAU/USD hold its ground, while the broad-based USD strength caps the pair's upside.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments. The technical outlook suggests further gains if INJ breaks above key resistance.

Hawkish Fed minutes and a market finding its footing

It was green across the board for US Stock market indexes at the close on Wednesday, with most S&P 500 names ending higher, adding 38 points (0.6%) to 6,881 overall. At the GICS sector level, energy led gains, followed by technology and consumer discretionary, while utilities and real estate posted the largest losses.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments.